Skip to main navigation
Skip to search
Skip to main content
Sort by
Nursing and Health Professions
Multiple Sclerosis
100%
Beta Interferon
100%
Interferon Beta Serine
100%
Recurrence Risk
60%
Beta1a Interferon
60%
Expanded Disability Status Scale
20%
Randomization
20%
Neutralizing Antibody
20%
Efficacy
20%
Keyphrases
Relapsing-remitting multiple Sclerosis
100%
Interferon beta-1a
100%
Interferon-β Therapy
100%
Annualized Relapse Rate
37%
Every Other Day
37%
Relapsing-remitting MS
25%
Time to First Relapse
25%
Expanded Disability Status Scale
12%
Neutralizing Antibodies
12%
Time to Progression
12%
MS Patients
12%
Antibody Formation
12%
Frequency of Administration
12%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Sclerosis
100%
Beta Interferon
100%
Interferon Beta Serine
100%
Recurrence Risk
60%
Beta1a Interferon
60%
Expanded Disability Status Scale
20%
Neutralizing Antibody
20%
Neuroscience
Relapsing Remitting Multiple Sclerosis
100%
Beta Interferon
100%
Interferon Beta 1b
100%
Interferon Beta 1a
60%
Expanded Disability Status Scale
20%
Neutralizing Antibody
20%